HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inappropriate antidiuretic hormone secretion after high dose vinblastine.

Abstract
We report on a patient with an embryonal teratocarcinoma of the testicle who had the syndrome of inappropriate secretion of antidiuretic hormone after receiving a high dose of vinblastine. His clinical course and laboratory studies are discussed. We suggest that patients receiving a high dose of vinblastine are at risk for the development of this syndrome.
AuthorsA Antony, W A Robinson, C Roy, W Pelander, R Donohue
JournalThe Journal of urology (J Urol) Vol. 123 Issue 5 Pg. 783-4 (May 1980) ISSN: 0022-5347 [Print] United States
PMID7420580 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Vinblastine
Topics
  • Adult
  • Humans
  • Inappropriate ADH Syndrome (chemically induced)
  • Male
  • Teratoma (drug therapy)
  • Testicular Neoplasms (drug therapy)
  • Vinblastine (adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: